Inside the Perimenopause Industrial Complex

Lisa Schrenk, a federal IT specialist in her early forties, struggled with severe depression and suicidal thoughts until she switched from oral contraceptives to bioidentical hormone therapy through the telehealth startup Midi, which, after five months of dosage adjustments, markedly improved her mood. The article notes that after a 2002 study suppressed hormone-therapy use, the Biden administration’s reversal has revived prescribing, affecting millions experiencing perimenopausal symptoms.